Clinical and Vaccine Immunology · 2013 · 30 citations · 43 references
Veterinary MedicineBiochemistryImmunologyImmunizationVaccine ImmunologyVaccinologyAdjuvant DesignRecombinant Protein VaccinesVaccinationVaccine DeliveryVaccine FormulationVaccine StabilityAdjuvant Effects On EfficacyAluminum AdjuvantsAluminum Salt AdjuvantsAluminum SaltsAnthrax VaccinesAntigen-adjuvant InteractionsBinding CapacityThermostability Enhancement
Aluminum salts are the most widely used vaccine adjuvants, and phosphate is known to modulate antigen-adjuvant interactions. Here we report an unexpected role for phosphate buffer in an anthrax vaccine (SparVax) containing recombinant protective antigen (rPA) and aluminum oxyhydroxide (AlOH) adjuvant (Alhydrogel). Phosphate ions bind to AlOH to produce an aluminum phosphate surface with a reduced rPA adsorption coefficient and binding capacity. However, these effects continued to increase as the free phosphate concentration increased, and the binding of rPA changed from endothermic to exothermic. Crucially, phosphate restored the thermostability of bound rPA so that it resembled the soluble form, even though it remained tightly bound to the surface. Batches of vaccine with either 0.25 mM (subsaturated) or 4 mM (saturated) phosphate were tested in a disease model at batch release, which showed that the latter was significantly more potent. Both formulations retained their potency for 3 years. The strongest aluminum adjuvant effects are thus likely to be via weakly attached or easily released native-state antigen proteins.
43
Modelling for Survival Data in Medical Research
Technometrics · 1995 · 2.2K citations
Crystal structure of the anthrax toxin protective antigen
Carlo Petosa, R. John Collier, Kurt R. Klimpel et al. · Nature · 1997 · 755 citations
Life Sciences, Biochemistry, Biology +14